Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.

Aird, Katherine M

Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. [electronic resource] - Cell cycle (Georgetown, Tex.) 2014 - 199-207 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

1551-4005

10.4161/cc.26953 doi


Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cell Proliferation
Cellular Senescence
DNA Damage
Epithelium--enzymology
Fallopian Tubes--enzymology
Female
Gene Knockdown Techniques
Humans
Ki-67 Antigen--metabolism
Middle Aged
Molecular Targeted Therapy
Neoplasm Grading
Neoplasm Staging
Neoplasms, Glandular and Epithelial--enzymology
Ovarian Neoplasms--enzymology
Ovary--enzymology
Ribonucleoside Diphosphate Reductase--genetics
Survival Rate